HR Must Identify Critical Roles to Reduce Talent Gaps in Succession Planning, Says McLean & Company
HR leaders must guide organizations in separating role criticality from individual performance to ensure operational continuity and long-term success, according to new research from McLean & Company. The HR research and advisory firm reports that organizations often struggle to distinguish roles
Brightland Homes Colorado Breaks Ground in the Master-planned Community of Windler
DENVER, Feb. 25, 2025 /PRNewswire/ — Brightland Homes, a leading name in the homebuilding industry and now entering their 11th Colorado community location, is thrilled to announce they are building in the masterplan of Windler in Aurora, CO. This significant development underscores the compan
Hearing Notice – CIRO to Hold a Disciplinary Hearing for Roberto Daniel Chu
VANCOUVER, BC, Feb. 25, 2025 /CNW/ – An initial appearance has been scheduled under the Investment Dealer and Partially Consolidated Rules before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) to set a date for a disciplinary hearing in the matter of Roberto Daniel C
" title="eMazzanti Technologies Pres. Carl Mazzanti To Speak On “The Digital Shield” At NJ Conference of Mayors
HOBOKEN, N.J., Feb. 25, 2025 /PRNewswire/ — Renowned Cyber Security and IT Solutions expert Carl Mazzanti has been selected to speak at a pivotal panel on The Digital Shield at the prestigious 2025 New Jersey Conference of Mayors Winter Summit. The must-attend event for NJ mayors will be held
PMPRB report shows higher-cost medicines driving a 14.1% growth in private plan drug costs in 2023
The report explores the drivers of growth in prescription drug costs for private drug plans OTTAWA, ON, Feb. 25, 2025 /CNW/ – The Patented Medicine Prices Review Board has published its latest report, Private Drug Plans in Canada: Expenditure Report, 2018–2023. This report provides insight
DAVE Investor News: Rosen Law Firm Encourages Dave Inc. Investors to Inquire About Securities Class Action Investigation – DAVE
NEW YORK, Feb. 25, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Dave Inc. (NASDAQ: DAVE) resulting from allegations that Dave may have issued materially misleading business in
XLCS Partners advises United Gasket on sale to All-State Industries
NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ — XLCS Partners, Inc., a leading middle-market investment bank, is pleased to announce it served as the exclusive advisor to United Gasket Corp. (“United Gasket”) on its acquisition by All-State Industries, Inc. (“All-State”)
Know Your Family’s Heart History
An important step in learning about hypertrophic cardiomyopathy MISSION, Kan., Feb. 25, 2025 /PRNewswire/ — (Family Features) Hypertrophic Cardiomyopathy (HCM) Awareness Day, observed every year on the last Wednesday of February, is a chance to shine a light on a heart condition that runs in f
e& delivers record revenue and net profit in FY 2024 growing consolidated revenue 10.1% to AED 59.2 billion
Net profit reached AED 10.8 billion, growing 4.3 per cent year-over-year Full year dividend per share of 83 fils e&’s footprint expanded to 38 countries with a subscriber base of 189.3 million across the Middle East, Asia, Africa, and Central and Eastern Europe e& emerged as the ̵
Sanochemia/SPL: Investigational Iron-Based MRI Contrast Agent Meets Primary Endpoints in Pivotal Phase III Study
NEUFELD, Austria, Feb. 25, 2025 /PRNewswire/ — Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen, The Netherlands). The multicentric prospective study
